← Leaderboards
Lichun Lu
Mayo Clinic Rochester
$5,236,018
Attributed
$10,057,611
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,057,611 · 3
By mechanism
R01$10,057,611 · 3
Top collaborators
- Michael J Yaszemski20 shared
- Benjamin D Elder3 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Wolfgang Singer$6,707,804
- Benjamin D Elder$701,688
- Hugo Giambini$97,463
Others in their field
Top investigators on “Operative Surgical Procedures”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Larry Arthur$195,389,208
- Norman Wolmark · Nsabp Foundation, Inc.$177,775,854
- Lawrence Corey · Fred Hutchinson Cancer Center$130,508,383
- Richard K. Wilson · Washington University$128,382,063
Research focus
Operative Surgical ProceduresInjectableDefectReconstructionVertebral ColumnBiocompatible MaterialsMinimally InvasiveBaseMechanicsProgramsSpinalDesignSpine Bone StructureHydrogelsPolymersPoly(Propylene Fumarate)CaringBoneCrosslinkApplications GrantsAffectMethodologyPre-ClinicalEvaluation
Grant awards (24)
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment - Master$475,317
R01 · FY2025 · AR · contact PI
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment - Master$445,734
R01 · FY2024 · AR · contact PI
Injectable and Moldable Composite Bone Scaffolds for Spinal Fusion$482,325
R01 · FY2023 · AR · contact PI
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment - Master$414,424
R01 · FY2023 · AR · contact PI
Injectable and Moldable Composite Bone Scaffolds for Spinal Fusion$523,072
R01 · FY2022 · AR · contact PI
Injectable and Moldable Composite Bone Scaffolds for Spinal Fusion$472,356
R01 · FY2021 · AR · contact PI
Injectable and Moldable Composite Bone Scaffolds for Spinal Fusion$67,282
R01 · FY2021 · AR · contact PI
Injectable and Moldable Composite Bone Scaffolds for Spinal Fusion$527,228
R01 · FY2020 · AR · contact PI
Injectable and Moldable Composite Bone Scaffolds for Spinal Fusion$50,463
R01 · FY2020 · AR · contact PI
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment - Master$430,335
R01 · FY2019 · AR · contact PI
Injectable and Moldable Composite Bone Scaffolds for Spinal Fusion$385,101
R01 · FY2019 · AR · contact PI
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment - Master$437,629
R01 · FY2018 · AR · contact PI
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment - Master$457,653
R01 · FY2017 · AR · contact PI
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment - Master$442,262
R01 · FY2016 · AR · contact PI
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment - Master$469,251
R01 · FY2015 · AR · contact PI
Injectable and Preformed Osteoinductive Biodegradable Composites$459,871
R01 · FY2014 · EB
Injectable and Preformed Osteoinductive Biodegradable Composites$393,715
R01 · FY2013 · EB
Injectable and Preformed Osteoinductive Biodegradable Composites$576,897
R01 · FY2012 · EB
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment$469,223
R01 · FY2012 · AR
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment$424,526
R01 · FY2011 · AR
Injectable and Preformed Osteoinductive Biodegradable Composites$337,480
R01 · FY2011 · EB
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment$414,949
R01 · FY2010 · AR
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment$476,926
R01 · FY2009 · AR
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment$423,592
R01 · FY2008 · AR